Oral cavity response to air pollutant exposure and association with pulmonary inflammation and symptoms in asthmatic children.

Journal Article (Journal Article)

Exposure to fine particulate matter (PM2.5 ) and ozone (O3 ) may lead to inflammation and oxidative damage in the oral cavity, which is hypothesized to contribute to the worsening of airway inflammation and asthma symptoms. In this panel study of 43 asthmatic children aged 5-13 years old, each child had 4 clinic visits with a 2-week interval between two consecutive visits. At each visit, saliva samples were collected and subsequently analyzed for interleukin 6 (IL-6) and eosinophil cationic protein (ECP) as biomarkers of inflammation and malondialdehyde (MDA) as a biomarker of oxidative stress in the oral cavity. At each visit, children were measured for fractional exhaled nitric oxide (FeNO) as a marker of pulmonary inflammation. Asthma symptoms of these children were measured using the Childhood Asthma Control Test (C-ACT). We found that an interquartile range (IQR) increase in 24-h average personal exposure to PM2.5 measured 1 and 2 days prior was associated with increased salivary IL-6 concentration by 3.0% (95%CI: 0.2%-6.0%) and 4.2% (0.7%-8.0%), respectively. However, we did not find a clear association between personal O3 exposure and any of the salivary biomarkers, except for a negative association between salivary MDA and O3 exposure measured 1 day prior. An IQR increase in salivary IL-6 concentration was associated with significantly increased FeNO by 28.8% (4.3%-53.4%). In addition, we found that increasing salivary IL-6 concentrations were associated with decreased individual and total C-ACT scores, indicating the worsening of asthma symptoms. We estimated that 13.2%-22.2% of the associations of PM2.5 exposure measured 1 day prior with FeNO and C-ACT scores were mediated by salivary IL-6. These findings suggest that the induction of inflammation in the oral cavity may have played a role in linking air pollution exposure with the worsening of airway inflammation and asthma symptoms.

Full Text

Duke Authors

Cited Authors

  • He, L; Norris, C; Cui, X; Li, Z; Barkjohn, KK; Teng, Y; Fang, L; Lin, L; Wang, Q; Zhou, X; Hong, J; Li, F; Zhang, Y; Schauer, JJ; Black, M; Bergin, MH; Zhang, JJ

Published Date

  • April 2022

Published In

Volume / Issue

  • 206 /

Start / End Page

  • 112275 -

PubMed ID

  • 34710437

Electronic International Standard Serial Number (EISSN)

  • 1096-0953

International Standard Serial Number (ISSN)

  • 0013-9351

Digital Object Identifier (DOI)

  • 10.1016/j.envres.2021.112275

Language

  • eng